MLN8237 for a Subject With Adenocarcinoma of the Prostate

NCT03005262 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: MLN8237

Sponsor

The University of Texas Health Science Center at San Antonio